Thermo Fisher Scientific: On The Road To Discovery


  • Thermo Fisher has seen impressive results, as headline results this year are held back by pandemic-related revenues on their retreat and a strong dollar.
  • Multiples have fallen to 20 times earnings, as higher interest rates have been a key driver behind this.
  • The appeal is luring, yet in this market, I would like to see a little further pullback before initiating a position here.

Thermo Fisher Scientific office in Whitby, On, Canada.


Shares of Thermo Fisher Scientific (NYSE:TMO) have been pressured as well, as part of a group of high valued companies which are hurt by the impact of higher interest rates.

After shares peaked at $670 early this year, shares are down

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!

Leave a Reply

Your email address will not be published. Required fields are marked *